Q192R paraoxonase gene 1 (PON1) polymorphism and atorvastatin therapy effect in patients with type 2 diabetes mellitus (T2DM)

Q192R paraoxonase gene 1 (PON1) polymorphism and atorvastatin therapy effect in patients with type 2 diabetes mellitus (T2DM)

Study objective: to estimate efficiency of atorvastatin therapy in patients with type 2 diabetes mellitus (T2DM), who are the carrier of various genotypes Q192R paraoxonase gene 1 (PON1). 386 T2DM patients, who have not received statin therapy before, and 187 healthy people were examined. All those...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Kim, S. A. Skoryukova, A. A. Bystrova, E. I. Baranova, S. N. Pchelina
Format:	Article
Language:	Russian
Published:	Academician I.P. Pavlov First St. Petersburg State Medical University 2015-03-01
Series:	Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:	сахарный диабет дислипидемия ген параоксоназы 1 аторвастатин diabetes mellitus dyslipidemia paraoxonase 1 gene atorvastatin
Online Access:	https://www.sci-notes.ru/jour/article/view/122
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Paraoxonase 1 gene polymorphisms in patients with type 2 diabetes mellitus
by: M. V. Kim, et al.
Published: (2014-06-01)

PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1
by: Cadiele Oliana Reichert, et al.
Published: (2025-02-01)

Exploring the Relationship between Canine Paraoxonase-1 (PON-1) Serum Activity and Liver Disease Classified by Clinico-Pathological Evaluation
by: Sara Meazzi, et al.
Published: (2024-10-01)

Investigation of PON1 activity and MDA levels in patients with epilepsy not receiving antiepileptic treatment
by: Dönmezdil N, et al.
Published: (2016-04-01)

Relationship between blood antioxidant paraoxonase-1 and the offspring yield in Hair goats
by: S. Dursun
Published: (2024-12-01)

The importance of paraoxonase 1 activity in chronic kidney disease
by: Elisabeth C. Samouilidou, et al.
Published: (2024-12-01)

GENOTYPES AND SERUM LEVELS OF APOLIPOPROTEIN E AND PARAOXONASE 1 IN CALCIFIC AORTIC VALVE STENOSIS
by: E. V. Shcheglova, et al.
Published: (2017-11-01)

Effect of hydroalcoholic extract of Tanacetum parthenium on gene expression and paraoxonase 1 enzyme activity: An experimental and molecular dynamic study
by: Javad Saffari-Chaleshtori, et al.
Published: (2024-09-01)

Role of paraoxonase 2 (PON2) as a potential biomarker and therapeutic target in cancer treatment
by: Vinayak Agarwal, et al.
Published: (2025-08-01)

SPECIFICS OF LIPID METABOLISM AND ATORVASTATIN EFFICACY IN TYPE 2 DIABETES WITH CARRIAGE OF VARIOUS POLYMORPHISMS OF CHOLESTEROL ETHER CARRYING PROTEIN TaqIB GENE
by: M. V. Kim, et al.
Published: (2015-10-01)

Effects of the storage of breast milk at different temperatures on total antioxidant capacity, total oxidant status, and paraoxonase-1 level
by: Murat Konak, et al.
Published: (2019-02-01)

The effect of 16 weeks of aerobic training on activity of serum paraoxonase, arylesterase, and lipid profile in postmenopausal women
by: R ghasemi, et al.
Published: (2017-10-01)

Role of Paraoxonase 2 in Airway Epithelial Response to Oxidant Stress
by: Matthew S. McCravy, et al.
Published: (2024-10-01)

Tetranectin and Paraoxonase 1 in Patients with Varying Stages of Heart Failure: A Cross-Sectional Analysis
by: Paula Alexandra Vulciu, et al.
Published: (2025-04-01)

Determination of paraoxonase enzyme and magnesium in women with arthritis in Balad city and evaluation of the correlation between them
by: Adnan Ali Sura, et al.
Published: (2025-01-01)

Study the levels of Leptin, and Adiponectin with Paraoxonase in Obese Individuals (male & female)
by: Entedhar R. Sarhat
Published: (2023-02-01)

OPTIMIZATION OF PARAOXONASE ORGANOPHOSPHATASE ACTIVITY ASSESSMENT IN MOUSE PLASMA USING PARAOXON-ETHYL
by: Okhovych A.R., et al.
Published: (2025-04-01)

Liraglutide Attenuates Atorvastatin-Induced Hepatotoxicity by Restoring GLP-1R Expression and Activating Nrf2 and Autophagy Pathways in Wistar Rats
by: Engy A. Elsiad, et al.
Published: (2025-07-01)

Inhibitory effects of Caveolin-1-m ediated atorvastatin on vasoconstriction of interlobar renal artery in SHR rats
by: XIE Xiao-ping, et al.
Published: (2017-01-01)

Пресс-релиз
Published: (2023-06-01)

Atorvastatin Calcium Enhances Ferroptosis in Breast Cancer Cells Through Mechanisms Involving DECR1
by: Yao Li, et al.
Published: (2025-06-01)

Aerobic-Resistance Training with Royal Jelly Supplementation Has a Synergistic Effect on Paraoxonase 1 Changes and Liver Function in Women with MASLD
by: Roya Askari, et al.
Published: (2025-02-01)

Expression of carboxylesterase and paraoxonase in the placenta and their association with chlorpyrifos exposure during pregnancy
by: Piuque M. Rodriguez, et al.
Published: (2025-06-01)

Evaluation of Serum Paraoxonase and Lipid Profile in Patients with Chronic Renal Failure Pre and post Hemodialysis
by: Entedhar R. Sarhat, et al.
Published: (2023-01-01)

Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with Dyslipidemia
by: Chen C, et al.
Published: (2024-12-01)

Thermodynamic Investigation of Partially Purified Paraoxonase in the Sera of Healthy Pregnant Women Compared to Women with Pregnancy Complication
by: Nabeel et al.
Published: (2019-12-01)

ESTERASE ACTIVITY AMONG PATIENTS WITH GASTROINTESTINAL DISEASES WORKING AT THE PLANTS PROVIDING STORAGE AND DISPOSAL OF ORGANOPHOSPHORUS COMPOUNDS
by: A. V. Fomichev, et al.
Published: (2017-03-01)

Lipidkorrigiruyushchie effekty nizkoy dozy atorvastatina u bol'nykh sakharnym diabetom tipa 2 i ozhireniem
by: M G Bubnova, et al.
Published: (2003-03-01)

Polimorfizm gena CTLA4 (49A/G) v russkoy populyatsii u bol'nykh sakharnym diabetom 1 tipa i zdorovykh donorov
by: D D Abramov, et al.
Published: (2007-09-01)

Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population
by: Mais N. Alqasrawi, et al.
Published: (2025-04-01)

Ниркові порушення у хворих на цукровий діабет 2 типу: потенційна роль поліморфізму A1166C (rs5186) гена рецептора ангіотензину II типу 1
by: Andriy Nesen, et al.
Published: (2025-02-01)

Polymorphism of S19W of apolipoprotein A5gene in patients with type 2 diabetes mellitus - connection with metabolic parameters and triglyceride levels
by: S. A. Skoryukova, et al.
Published: (2015-06-01)

NOT PON1 L55M BUT ACE I/D VARIANT MIGHT BE A RISK FACTOR FOR OSCC IN THE TURKISH POPULATION
by: Ayşe Feyda Nursal, et al.
Published: (2025-03-01)

Polimorfizm gena angiotenzinprevrashchayushchego fermenta pri sakharnom diabete 1 tipa u detey Sibiri
by: E I Kondrat'eva, et al.
Published: (2001-12-01)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)

Analysis of the binary mixtures of amlodipine and atorvastatin by chemometric-spectophotometric method
by: Hayrettin Bulum, et al.
Published: (2025-06-01)

Lipid-lowering effectiveness of a Russian generic of atorvastatin in patients with various hyperlipidaemia phenotypes
by: P. P. Malyshev, et al.
Published: (2009-12-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY
by: A. V. Semenov, et al.
Published: (2016-01-01)

Vliyanie kompensatsii uglevodnogo obmenai terapii atorvastatinom na lipidnyy obmen i uroven' S-reaktivnogo belka u patsientov s sakharnym diabetom 2 tipa
by: Irina Vladimirovna Glinkina, et al.
Published: (2007-03-01)